Other treatment

DRUG5 trials

Sponsors

Xijing Hospital, Novartis Pharmaceuticals, Region Stockholm, Minia University

Conditions

Bell's PalsyCOPDImmunoglobulin A NephropathyIrreversible PulpitisMultiple SclerosisPregnancy

Phase 4

A 1-year Multi-center, Prospective, Cohort Study in Patients With Chronic Obstructive Pulmonary Disease Treated With Long-acting Bronchodilator

CompletedNCT01794780

Novartis PharmaceuticalsCOPD

Start: 2013-02-05End: 2015-05-25Updated: 2019-09-26

Unknown Phase

Prednisone and Acupuncture for the Treatment of Facial Neuritis: a Multiple Center, CER in China

Xijing HospitalBell's Palsy

Start: 2010-09-30End: 2015-04-30Target: 1800Updated: 2014-08-20

A Mobile App-Based Study to Evaluate Disease Burden and Treatment Patterns in Immunoglobulin A Nephropathy (IgAN) in the US

RecruitingNCT06952426

Novartis PharmaceuticalsImmunoglobulin A Nephropathy

Start: 2025-03-04End: 2025-06-30Target: 300Updated: 2025-06-17

Immune System Effects in Children Born to Women With Multiple Sclerosis Treated With Monoclonal Antibody Therapy During Pregnancy

Not yet recruitingNCT07149662

Region StockholmMultiple Sclerosis, Pregnancy

Start: 2026-02-28End: 2028-03-31Target: 111Updated: 2025-11-25

CGF Partial Pulpotomy Versus Endodontic Treatment

Not yet recruitingNCT07417098

Minia UniversityIrreversible Pulpitis

Start: 2026-01-20End: 2028-01-25Target: 60Updated: 2026-02-18

Related Papers

Prednisolone and acupuncture in Bell's palsy: study protocol for a randomized, controlled trial.

2011-06-215 citations